EP2 antagonists (Amgen)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameEP2 antagonists (Amgen)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProstanoid EP2 receptor antagonists

TargetsProstanoid EP2 receptor

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAmgen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmgen Inc

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

ATC CodeN/A